MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock, net of...
$34,908,593
Proceeds from issuance of
warrants, net of issuance...
$16,986,830
Proceeds from warrant
exercises
$1,264,632
Proceeds from sale of
investments
$14,271,128
Proceeds from stock
option exercises
$823
Proceeds from maturity of
investments
$5,000,000
Net cash provided by
financing activities
$53,050,095
Net cash provided by
investing activities
$14,039,357
Canceled cashflow
$110,783
Canceled cashflow
$5,231,771
(decrease) increase in cash
and cash...
-$21,539,978
Canceled cashflow
$67,089,452
Non-cash stock-based
compensation
$3,755,788
Amortization of operating
lease right-of-use...
$1,570,917
Depreciation
$1,417,913
Prepaid expenses and
other current assets,...
-$1,105,639
Loss on sales of
short-term investments
-$890,916
Taxes paid related to
net share...
-$110,783
Purchases of investments
$4,946,073
Purchases of capital
assets
$285,698
Net cash used in
operating activities
-$88,629,430
Canceled cashflow
$8,741,173
Net loss
-$84,945,901
Accounts payable and
accrued expenses,...
-$6,423,085
Operating lease
right-of-use assets and...
-$2,497,361
Accrued clinical trial
expenses
-$1,371,180
Net unrealized gain
on...
$1,114,781
Change in fair value of
common stock warrant...
-$493,231
(gain) loss on equity
investment in affiliated...
$489,844
Other assets
$32,821
Amortization of discounts on
investments
$2,399
Back
Back
Cash Flow
source: myfinsight.com
INOVIO PHARMACEUTICALS, INC. (INO)
INOVIO PHARMACEUTICALS, INC. (INO)